Pro Share Advisors LLC Seelos Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.51 - $0.93 $9,393 - $17,129
-18,419 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$0.84 - $1.71 $2,556 - $5,203
-3,043 Reduced 14.18%
18,419 $15,000
Q4 2021

Feb 08, 2022
BUY
$1.59 - $2.38 $14,111 - $21,122
8,875 Added 70.51%
21,462 $35,000
Q3 2021

Nov 12, 2021
SELL
$1.69 - $2.89 $11,966 - $20,464
-7,081 Reduced 36.0%
12,587 $30,000
Q2 2021

Aug 13, 2021
BUY
$2.64 - $6.32 $51,923 - $124,301
19,668 New
19,668 $52,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $32M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email